N-Phenylcyclopentanecarboxamide

Catalog No.: 
ACNXLM658
CAS No.: 
3400-41-7
Molecular Formula: 
C12H15NO
Molecular Weight: 
189.26
N-Phenylcyclopentanecarboxamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$67.00In stockInquiry
1g95%$188.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-Phenylcyclopentanecarboxamide
IUPAC NameN-phenylcyclopentanecarboxamide
Molecular FormulaC12H15NO
Molecular Weight189.26
SMILESO=C(C1CCCC1)NC2=CC=CC=C2
InChI KeyFRABTSINMBZPJB-UHFFFAOYSA-N
SynonymCyclopentanecarboxaMide, N-phenyl-;n-Phenylcyclopentanecarboxamide;Phenylcyclopentanecarboxamide
CAS No.3400-41-7

Safety Data

Pictogram
CorrosiveHarmful or irritant
Signal Word
Danger
Hazard Statement(s)
H302-H315-H318-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P310-P330-P332+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACNXLM658 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACWGDT861 route compound structure diagram
    ACWGDT8614524-93-0In Stock
  4. Then
  5. ACNXLM658 route product structure diagram
    ACNXLM6583400-41-7In Stock
Inquiry

2. ACNXLM658 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACQCVY160 route compound structure diagram
    ACQCVY1603400-45-1In Stock
  4. Then
  5. ACNXLM658 route product structure diagram
    ACNXLM6583400-41-7In Stock
Inquiry

3. ACNXLM658 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACNXLM658 route product structure diagram
    ACNXLM6583400-41-7In Stock
Inquiry

Comments (0)